Diversity-promoting Institutions Drug Abuse Research Program (DIDARP) (R24)

The summary for the Diversity-promoting Institutions Drug Abuse Research Program (DIDARP) (R24) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Diversity-promoting Institutions Drug Abuse Research Program (DIDARP) (R24): Purpose. This FOA issued by the National Institute on Drug Abuse (NIDA), National Institutes of Health, encourages Resource-Related Research Project Grant (R24) applications from institutions that serve economically disadvantaged students andcommunities.Applications should propose to develop or strengthen the drug abuse research infrastructure at the institution and foster the research career development of a diverse cadre of faculty, students and staff who are currently underrepresented in drug abuse research. Mechanism of Support. This FOA will utilize the Resource-Related Research Projects (R24) grant mechanism. Funds Available and Anticipated Number of Awards. For this funding opportunity, budgets up to $350,000 in directcosts per year and time periods up to 5 years may be requested.Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards supported will depend upon the mechanism number, quality, duration, and cost of the applications received. Budget and Project Period.Budgets for direct costs of up to $350,000 per year and project duration of up to 5 years may be requested.

Federal Grant Title:	Diversity-promoting Institutions Drug Abuse Research Program (DIDARP) (R24)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Education Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PAR-11-060
Type of Funding:	Grant
CFDA Numbers:	93.279
CFDA Descriptions:	Drug Abuse and Addiction Research Programs
Current Application Deadline:	Sep 09, 2013
Original Application Deadline:	Sep 09, 2013
Posted Date:	Dec 06, 2010
Creation Date:	Dec 06, 2010
Archive Date:	Oct 10, 2013
Total Program Funding:
Maximum Federal Grant Award:	$350,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Public and State controlled institutions of higher education - Private institutions of higher education - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs) .
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants: • Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...; • Education Activities for Responsible Analyses of Complex, Large-Scale Data (R25- Clinical ...; • Research on the Neuro-Immune Axis in the context of HIV and Substance Use (R01 Clinical Tr...; • Research on the Neuro-Immune Axis in the Context of HIV and Substance Use (R21 Clinical Tr...; • Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial option...; • NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards; • Drug Abuse Aspects of Hiv/Aids and Other Infections; • Epidemiology of Drug Abuse
More Grants from the National Institutes of Health: • SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies...; • Small Business Transition Grant For Early Career Scientists (R41/R42 Clinical Trial Not Al...; • Cystic Fibrosis Research and Translation Centers (P30 Clinical Trial Optional); • Mentored Quantitative Research Development Award (Parent K25 Independent Clinical Trial No...; • Mentored Quantitative Research Development Award (Parent K25 Independent Basic Experimenta...